Skip to main content

Table 1 Type 2 diabetes association for the 11 AGPAT6 variants genotyped in type 2 diabetic individuals and control individuals with normal glucose tolerance

From: Studies of association of AGPAT6variants with type 2 diabetes and related metabolic phenotypes in 12,068 Danes

AGPAT6variant

N

Minor:major allele

MAF

Odds ratio

P-value

(95% CI)

T2D

NGT

(wildtype/hetero-/homozygous)

(wildtype/hetero-/homozygous)

rs13252523

1428/2304/802

1821/2840/1148

G:A

0.44

0.95 (0.88-1.01)

0.098

rs7357415

2779/1555/197

3546/1973/293

T:A

0.22

0.95 (0.87-1.03)

0.19

rs2977860

2158/1931/386

2827/2419/478

T:C

0.30

1.03 (0.95-1.1)

0.49

rs11785763

3364/1095/94

4307/1405/116

G:A

0.14

0.99 (0.90-1.08)

0.79

rs999188

1379/2271/875

1802/2817/1169

T:G

0.44

1.00 (0.94-1.07)

0.98

rs17600159

3941/581/13

5123/658/16

G:A

0.063

1.12 (0.98-1.29)

0.092

rs2977845

4124/433/12

5332/513/15

G:A

0.048

1.18 (1.01-1.37)

0.034

rs10504041

2980/1359/169

3738/1814/256

G:A

0.19

0.91 (0.84-0.99)

0.030

rs12677439

2568/1709/271

3374/2062/343

T:C

0.24

1.06 (0.99-1.15)

0.11

rs6988044

3993/566/15

5028/786/31

G:A

0.069

0.87 (0.76-0.99)

0.030

rs890220

3376/1107/85

4188/1468/151

G:A

0.15

0.88 (0.80-0.96)

0.0052

  1. P-values and odds ratios were calculated by logistic regression analysis assuming an additive genetic model and adjusting for age and sex. Effects were calculated for the minor allele. T2D Type 2 diabetes, NGT Normal glucose tolerance, MAF Minor allele frequency.